Wire Stories
-
403Seoul Semiconductor Presents New Proposal for SunLike-Enabled Future Smart Farm
SEOUL, South Korea–(BUSINESS WIRE)–#Acrich—Seoul Semiconductor Co., Ltd. (KOSDAQ:046890), a global optical semiconductor company, announced on December 18 that it has verified through...
-
433Promising Korean ICT Company and Metaverse Innovator Connects Global Markets with ICT WOW Platform
SEOUL, South Korea–(BUSINESS WIRE)–#ICT–The National IT Industry Promotion Agency (Director Heo Seong-wook), under the Ministry of Science and ICT, announced the successful...
-
381APAC Water Outlook 2024 – Circular Economy-based Policies Driving Growth in New Water and Wastewater Infrastructure Investments – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “APAC Water Outlook 2024” report has been added to ResearchAndMarkets.com’s offering. By 2050, about 1 billion people will reside in...
-
462“Gora Kadan” opened “Sushi Kadan” on November 4, 2023
HAKONE, Japan–(BUSINESS WIRE)–Since its establishment in 1952, Gora Kadan has instilled itself as a favorite destination among guests from both Japan and...
-
555Luxury Carrier STARLUX Airlines Expands US Network; Celebrates Inaugural San Francisco to Taiwan Flight and its Second U.S. Destination
Gate launch event rings in new route to Taipei and onward to 20 Asian destinations SAN FRANCISCO & TAIPEI, Taiwan–(BUSINESS WIRE)–Taiwan-based luxury...
-
364Propanc Biopharma Engages Boutique Advisory Firm to Identify Strategic Investment Opportunities
MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering...
-
422CrowdStrike and Optiv Surpass $1 Billion in Sales
Premier partnership surpasses key milestone, modernizing and consolidating cybersecurity for thousands of organizations AUSTIN, Texas–(BUSINESS WIRE)–CrowdStrike (NASDAQ: CRWD) announced that Optiv, the...
-
372AnHeart Therapeutics and Innovent Announce China’s NMPA Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation
NEW YORK & SUZHOU, China–(BUSINESS WIRE)–AnHeart Therapeutics (“AnHeart”), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, and...
-
398Global Subscription Video on Demand (SVOD) Forecasts Report 2023-2029 with Profiles of Netflix, Disney+, Paramount+, HBO Max, Amazon Prime Video and Apple TV+ – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global SVOD Forecasts Update 2029” report has been added to ResearchAndMarkets.com’s offering. Global SVOD subscriptions will increase by 321 million...
-
397Two Phase 3 Trials of Datopotamab Deruxtecan Plus Durvalumab Initiated in Patients Across Two Breast Cancer Subtypes
TROPION-Breast04 is evaluating Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab as neoadjuvant treatment for early-stage triple negative and HR low, HER2...
